Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance

Bibliographic Details
Main Authors: Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578920301144
_version_ 1818391632302571520
author Johnathan Oh
Minal Barve
Neil Senzer
Phylicia Aaron
Luisa Manning
Gladice Wallraven
Ernest Bognar
Laura Stanbery
Staci Horvath
Meghan Manley
John Nemunaitis
Adam Walter
Rodney P. Rocconi
author_facet Johnathan Oh
Minal Barve
Neil Senzer
Phylicia Aaron
Luisa Manning
Gladice Wallraven
Ernest Bognar
Laura Stanbery
Staci Horvath
Meghan Manley
John Nemunaitis
Adam Walter
Rodney P. Rocconi
author_sort Johnathan Oh
collection DOAJ
first_indexed 2024-12-14T05:16:36Z
format Article
id doaj.art-e43f4809d0e54d0cba6c51742a18b756
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-12-14T05:16:36Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-e43f4809d0e54d0cba6c51742a18b7562022-12-21T23:15:49ZengElsevierGynecologic Oncology Reports2352-57892020-11-0134100648Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenanceJohnathan Oh0Minal Barve1Neil Senzer2Phylicia Aaron3Luisa Manning4Gladice Wallraven5Ernest Bognar6Laura Stanbery7Staci Horvath8Meghan Manley9John Nemunaitis10Adam Walter11Rodney P. Rocconi12Texas Oncology, P.A., Dallas, TX, United StatesTexas Oncology, P.A., Dallas, TX, United States; Mary Crowley Cancer Research Centers, Dallas, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesCorresponding author at: 2545 Golden Bear Dr., Suite 110, Carrollton, TX 75006, United States.; Gradalis, Inc., Carrolton, TX, United StatesProMedica, Toledo, OH, United StatesUniversity of South Alabama - Mitchell Cancer Institute, Mobile, AL, United Stateshttp://www.sciencedirect.com/science/article/pii/S2352578920301144
spellingShingle Johnathan Oh
Minal Barve
Neil Senzer
Phylicia Aaron
Luisa Manning
Gladice Wallraven
Ernest Bognar
Laura Stanbery
Staci Horvath
Meghan Manley
John Nemunaitis
Adam Walter
Rodney P. Rocconi
Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
Gynecologic Oncology Reports
title Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_full Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_fullStr Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_full_unstemmed Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_short Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_sort long term follow up of phase 2a trial results involving advanced ovarian cancer patients treated with vigil r in frontline maintenance
url http://www.sciencedirect.com/science/article/pii/S2352578920301144
work_keys_str_mv AT johnathanoh longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT minalbarve longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT neilsenzer longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT phyliciaaaron longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT luisamanning longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT gladicewallraven longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT ernestbognar longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT laurastanbery longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT stacihorvath longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT meghanmanley longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT johnnemunaitis longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT adamwalter longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT rodneyprocconi longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance